Literature DB >> 11303624

Expression of vascular endothelial growth factor-b in human astrocytoma.

J C Gollmer1, A Ladoux, J Gioanni, P Paquis, A Dubreuil, M Chatel, C Frelin.   

Abstract

Growth of human malignant gliomas is stringently dependent on an angiogenic process that probably involves vascular endothelial growth factor (VEGF). Expressions of mRNA coding for the different forms of VEGF were analyzed in surgical specimens from human astrocytomas. Low levels of placental growth factor (PGF) and VEGFC mRNA were observed in polymerase chain reaction, but not in Northern blot experiments. VEGF mRNA was found in some but not all grade and grade IV astrocytomas. VEGFB mRNA was observed in all tissue samples analyzed irrespective of the tumor grade. A new splice variant of VEGFB (VEGFB155) that lacks exons 5 and 6 is described. Expressions of VEGF mRNA in cultured glioblastomas cells were upregulated by hypoxia, but the sensitivity of the cells to hypoxia was reduced as compared with normal rat astrocytes. VEGF expression was depressed by dexamethasone. Expressions of VEGFB mRNA were affected neither by hypoxia nor by dexamethasone. The results indicate a coexpression of VEGF mRNA and VEGFB mRNA in human astrocytomas. Expression of VEGFB is markedly different from that of VEGF. Possible roles of VEGFB as a cofactor for hypoxia-induced angiogenesis in human astrocytomas are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11303624      PMCID: PMC1919514          DOI: 10.1093/neuonc/2.2.80

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  5 in total

1.  A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.

Authors:  Louis B Nabors; John B Fiveash; James M Markert; Manasi S Kekan; George Y Gillespie; Zhi Huang; Martin J Johnson; Sreelatha Meleth; Huichien Kuo; Candece L Gladson; Hassan M Fathallah-Shaykh
Journal:  Arch Neurol       Date:  2010-03

Review 2.  Genetic and hypoxic regulation of angiogenesis in gliomas.

Authors:  Balveen Kaur; Chalet Tan; Daniel J Brat; Dawn E Post; Erwin G Van Meir
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Verifying expressed transcript variants by detecting and assembling stretches of consecutive exons.

Authors:  Tzu-Hung Hsiao; Chien-Hong Lin; Te-Tsui Lee; Ji-Yen Cheng; Pei-Kuen Wei; Eric Y Chuang; Konan Peck
Journal:  Nucleic Acids Res       Date:  2010-08-26       Impact factor: 16.971

4.  Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.

Authors:  Huicong Zhou; Zhiliang He; Changdong Wang; Tingting Xie; Lin Liu; Chuanyang Liu; Fangzhou Song; Yongping Ma
Journal:  Int J Mol Sci       Date:  2016-06-06       Impact factor: 5.923

5.  Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB.

Authors:  Karin Boer; Dirk Troost; Wim G M Spliet; Peter C van Rijen; Jan A Gorter; Eleonora Aronica
Journal:  Acta Neuropathol       Date:  2008-03-04       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.